5^th European Bronchiectasis Workshop & 9th International Forum on Respiratory Tract Infections

J8–11 February 2027

London, United Kingdom

• Basic Science: aetiology & pathophysiology
• Clinical Trials
• Comorbidities: AATD, Asthma, COPD, etc.
• Cystic Fibrosis and Bronchiectasis
• Immunology & Inflammation: including ABPA, inborn errors of immunity, primary immunodeciency, neutrophil function/dysfunction
• Infections: Pseudomonas, Haemophilus, etc.
• Management & Organisation of a clinical service
• NTM — Nontuberculous Mycobacteria
• Nurses and Allied Healthcare Professionals experiences
• Paediatric Bronchiectasis
• Patient experience
• PCD — Primary Ciliary Dyskinesia
• Respiratory Physiotherapy & Airway Clearance
• Registries
• Treatments

European Bronchiectasis Network (EMBARC) – EBROW Respiratory

Tract Infections Forum – RTI

• James D. Chalmers
• Charles Haworth
• Michael Loebinger

The congress is structured into three scientific tracks:

• EBROW: Bronchiectasis management, clinical trials, exacerbations, artificial intelligence, remote monitoring, and emerging treatment strategies.
• Joint EBROW & RTI Track: Bronchiectasis, fungal infections, non-tuberculous mycobacteria (NTM), and complex respiratory pathogens.
• RTI: Pneumonia, tuberculosis, RSV, COVID-19, innovative antiviral therapies, and rapid diagnostic methods.